Targeting molecular pathways to control immune checkpoint inhibitor toxicities
Immune checkpoint inhibitors (ICIs) have transformed cancer treatment but are frequently associated with immune-related adverse events (irAEs). This article offers a novel synthesis of findings from both preclinical and clinical studies, focusing on the molecular mechanisms driving irAEs across dive...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
27 December 2024
|
| In: |
Trends in immunology
Year: 2025, Volume: 46, Issue: 1, Pages: 61-73 |
| ISSN: | 1471-4981 |
| DOI: | 10.1016/j.it.2024.11.014 |
| Online Access: | Verlag, kostenfrei, Volltext: https://doi.org/10.1016/j.it.2024.11.014 Verlag, kostenfrei, Volltext: https://www.sciencedirect.com/science/article/pii/S1471490624002990?via%3Dihub 
|
| Author Notes: | Robin Reschke, Ryan J. Sullivan, Evan J. Lipson, Alexander H. Enk, Thomas F. Gajewski, and Jessica C. Hassel |
MARC
| LEADER | 00000naa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1937003841 | ||
| 003 | DE-627 | ||
| 005 | 20250925171748.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 250925s2025 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.it.2024.11.014 |2 doi | |
| 035 | |a (DE-627)1937003841 | ||
| 035 | |a (DE-599)KXP1937003841 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Reschke, Robin Niklas |d 1989- |e VerfasserIn |0 (DE-588)113859038X |0 (DE-627)896092011 |0 (DE-576)492596956 |4 aut | |
| 245 | 1 | 0 | |a Targeting molecular pathways to control immune checkpoint inhibitor toxicities |c Robin Reschke, Ryan J. Sullivan, Evan J. Lipson, Alexander H. Enk, Thomas F. Gajewski, and Jessica C. Hassel |
| 264 | 1 | |c 27 December 2024 | |
| 300 | |a 13 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 25.09.2025 | ||
| 520 | |a Immune checkpoint inhibitors (ICIs) have transformed cancer treatment but are frequently associated with immune-related adverse events (irAEs). This article offers a novel synthesis of findings from both preclinical and clinical studies, focusing on the molecular mechanisms driving irAEs across diverse organ systems. It examines key immune cells, such as T cell subsets and myeloid cells, which are instrumental in irAE pathogenesis, alongside an in-depth analysis of cytokine signaling [interleukin (IL)-6, IL-17, IL-4), interferon γ (IFN-γ), IL-1β, tumor necrosis factor α (TNF-α)], integrin-mediated interactions [integrin subunits αITGA)4 and ITGB7], and microbiome-related factors that contribute to irAE pathology. This exploration of modifiable pathways uncovers new opportunities to mitigate irAEs by using available antibodies (Abs) that target key inflammatory molecules across tumor types, while ideally preserving the antitumor efficacy of ICIs. | ||
| 650 | 4 | |a immune-related adverse events | |
| 650 | 4 | |a immunotherapy | |
| 650 | 4 | |a personalized medicine | |
| 650 | 4 | |a targeted therapy | |
| 650 | 4 | |a toxicities | |
| 700 | 1 | |a Sullivan, Ryan J. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Lipson, Evan J. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Enk, Alexander |d 1963- |e VerfasserIn |0 (DE-588)1032757140 |0 (DE-627)739272535 |0 (DE-576)166173517 |4 aut | |
| 700 | 1 | |a Gajewski, Thomas F. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Hassel, Jessica C. |d 1975- |e VerfasserIn |0 (DE-588)129790702 |0 (DE-627)480399069 |0 (DE-576)29783715X |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Trends in immunology |d Amsterdam [u.a.] : Elsevier Science, 2001 |g 46(2025), 1 vom: Jan., Seite 61-73 |h Online-Ressource |w (DE-627)325793301 |w (DE-600)2040190-5 |w (DE-576)103868356 |x 1471-4981 |7 nnas |a Targeting molecular pathways to control immune checkpoint inhibitor toxicities |
| 773 | 1 | 8 | |g volume:46 |g year:2025 |g number:1 |g month:01 |g pages:61-73 |g extent:13 |a Targeting molecular pathways to control immune checkpoint inhibitor toxicities |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.it.2024.11.014 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u https://www.sciencedirect.com/science/article/pii/S1471490624002990?via%3Dihub |x Verlag |z kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20250925 | ||
| 993 | |a Article | ||
| 994 | |a 2025 | ||
| 998 | |g 129790702 |a Hassel, Jessica C. |m 129790702:Hassel, Jessica C. |d 910000 |d 911300 |d 50000 |e 910000PH129790702 |e 911300PH129790702 |e 50000PH129790702 |k 0/910000/ |k 1/910000/911300/ |k 0/50000/ | ||
| 998 | |g 1032757140 |a Enk, Alexander |m 1032757140:Enk, Alexander |d 910000 |d 911300 |e 910000PE1032757140 |e 911300PE1032757140 |k 0/910000/ |k 1/910000/911300/ | ||
| 998 | |g 113859038X |a Reschke, Robin Niklas |m 113859038X:Reschke, Robin Niklas |d 910000 |d 911300 |e 910000PR113859038X |e 911300PR113859038X |k 0/910000/ |k 1/910000/911300/ |p 1 |x j | ||
| 999 | |a KXP-PPN1937003841 |e 4776055961 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"id":{"doi":["10.1016/j.it.2024.11.014"],"eki":["1937003841"]},"name":{"displayForm":["Robin Reschke, Ryan J. Sullivan, Evan J. Lipson, Alexander H. Enk, Thomas F. Gajewski, and Jessica C. Hassel"]},"recId":"1937003841","physDesc":[{"extent":"13 S."}],"title":[{"title":"Targeting molecular pathways to control immune checkpoint inhibitor toxicities","title_sort":"Targeting molecular pathways to control immune checkpoint inhibitor toxicities"}],"note":["Gesehen am 25.09.2025"],"language":["eng"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"person":[{"display":"Reschke, Robin Niklas","given":"Robin Niklas","role":"aut","family":"Reschke"},{"display":"Sullivan, Ryan J.","family":"Sullivan","given":"Ryan J.","role":"aut"},{"display":"Lipson, Evan J.","given":"Evan J.","role":"aut","family":"Lipson"},{"display":"Enk, Alexander","family":"Enk","role":"aut","given":"Alexander"},{"display":"Gajewski, Thomas F.","family":"Gajewski","given":"Thomas F.","role":"aut"},{"family":"Hassel","given":"Jessica C.","role":"aut","display":"Hassel, Jessica C."}],"relHost":[{"language":["eng"],"type":{"media":"Online-Ressource","bibl":"periodical"},"note":["Gesehen am 21.11.23"],"id":{"eki":["325793301"],"issn":["1471-4981"],"zdb":["2040190-5"]},"title":[{"title":"Trends in immunology","title_sort":"Trends in immunology"}],"part":{"text":"46(2025), 1 vom: Jan., Seite 61-73","extent":"13","issue":"1","pages":"61-73","volume":"46","year":"2025"},"origin":[{"dateIssuedKey":"2001","dateIssuedDisp":"2001-","publisherPlace":"Amsterdam [u.a.]","publisher":"Elsevier Science"}],"pubHistory":["22.2001 -"],"disp":"Targeting molecular pathways to control immune checkpoint inhibitor toxicitiesTrends in immunology","physDesc":[{"extent":"Online-Ressource"}],"recId":"325793301"}],"origin":[{"dateIssuedKey":"2025","dateIssuedDisp":"27 December 2024"}]} | ||
| SRT | |a RESCHKEROBTARGETINGM2720 | ||